back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-08-25 14:11 Tx date 2026-08-20 |
$BRE
Bridgemarq Real Estate Services Inc. (Formerly Brookfield Real Estate Services Inc.) |
Freedman, Joseph Stuart
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Deferred Share Unit
56 - Grant of rights
|
+26,901 vol |
26,901 | |
| Filed 2026-08-25 14:11 Tx date 2015-01-14 |
$BRE
Bridgemarq Real Estate Services Inc. (Formerly Brookfield Real Estate Services Inc.) |
Freedman, Joseph Stuart
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Deferred Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-08-17 17:55 Tx date 2026-08-13 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Yale Freedman (Control or Direction)
|
Common Shares
99 - Correction of information
|
+2,000 vol |
38,945 | |
| Filed 2026-08-17 17:53 Tx date 2026-08-13 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Maya Freedman (Control or Direction)
|
Common Shares
99 - Correction of information
|
+5 vol |
38,707 | |
| Filed 2026-08-17 17:51 Tx date 2026-08-13 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Harriet Feinstein (Control or Direction)
|
Common Shares
99 - Correction of information
|
-200 vol |
337,710 | |
| Filed 2026-06-18 14:11 Tx date 2025-12-15 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+10,000 vol |
10,000 | |
| Filed 2025-12-22 18:43 Tx date 2025-12-15 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
$86,300
+10,000 vol $8.63 each |
||
| Filed 2026-03-18 18:36 Tx date 2026-03-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Harriet Feinstein (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,518
+1,700 vol $10.89 each |
337,910 | |
| Filed 2026-03-18 18:35 Tx date 2026-03-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Harriet Feinstein (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,638
+1,800 vol $10.91 each |
336,210 | |
| Filed 2026-03-18 18:35 Tx date 2026-03-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Harriet Feinstein (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,352
+400 vol $10.88 each |
334,410 | |
| Filed 2026-03-18 18:34 Tx date 2026-03-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Maya Freedman (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,026
+1,929 vol $10.90 each |
38,702 | |
| Filed 2026-03-18 18:33 Tx date 2026-03-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Maya Freedman (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,084
+1,300 vol $10.83 each |
36,773 | |
| Filed 2026-03-18 18:31 Tx date 2026-03-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Yale Freedman (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,168
+1,800 vol $10.65 each |
36,945 | |
| Filed 2026-03-18 18:30 Tx date 2026-03-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Benjamin Freedman (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$39,385
+3,874 vol $10.17 each |
37,019 | |
| Filed 2026-03-18 18:28 Tx date 2026-03-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$45,003
+4,200 vol $10.71 each |
11,237 | |
| Filed 2026-03-18 18:23 Tx date 2026-03-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,533
+1,700 vol $10.90 each |
1,632,470 | |
| Filed 2026-03-02 16:30 Tx date 2026-03-02 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Benjamin Freedman (Indirect Ownership)
|
Common Shares
54 - Exercise of warrants
|
$60,000
+20,000 vol $3.00 each |
33,145 | |
| Filed 2026-03-02 16:28 Tx date 2026-03-02 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: The Freedman Family Trust (Indirect Ownership)
|
Common Shares
54 - Exercise of warrants
|
$450,000
+150,000 vol $3.00 each |
387,300 | |
| Filed 2026-03-02 16:26 Tx date 2026-03-02 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: The Freedman Family Trust (Indirect Ownership)
|
Warrants
54 - Exercise of warrants
|
$-510,000
-170,000 vol $3.00 each |
0 | |
| Filed 2026-02-21 14:03 Tx date 2026-02-20 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: RRSP (Control or Direction)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$67,484
+7,037 vol $9.59 each |
7,037 |